TrialDiabetic medicine : a journal of the British Diabetic Association2018

Pharmacokinetic and pharmacodynamic profile of the sodium-glucose co-transporter-2 inhibitor empagliflozin in young people with Type 2 diabetes: a randomized trial.

L M B Laffel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.